Barry Cheskin, co-founder, president, and CEO of PowerVision Inc., delivers an update on the company’s next iteration of IOL, Fluidvision 2020. Cheskin tells OIS-TV the company is enrolling patients in a clinical trial to test the new IOL, which stands to provide nearly double the improvement over previous iterations.
Barry Cheskin is Co-Founder, President & CEO of PowerVision. Mr. Cheskin has over 20 years of general management experience in the medical device business. Prior to PowerVision, he was President & CEO of medical device start-up, NanoGram Devices, which he sold to his largest competitor.